effect
dehydroepiandrosterone
17hydroxycorti
costeroids
plasma
various
stages
cancer
diseases
breast
reducing
effect
dehydroepiandrosterone
plasma
corticosteroids
average
shortened
advanced
stage
iv
cases
breast
cancer
groups
patients
lowest
corticosteroid
levels
found
hr
infusion
dehydroepiandrosteronephosphate
patients
mastopathy
effect
still
detectable
hr
later
patients
breast
cancer
stage
iv
initial
levels
reached
time
cases
stages
i
ii
lesions
findings
intermediate
shortening
attributed
a
intensive
transformation
dehydroepiandrosterone
advanced
cases
breast
cancer
